The justices rejected Lilly's appeal of a lower court's ruling, which upheld a $183 million judgment from a whistleblower lawsuit against the drugmaker for defrauding Medicaid
Bookmark popover
The U.S. Supreme Court on Monday declined to hear a challenge from drugmaker Eli Lilly to a Civil War-era whistleblower law. This law has recovered billions of dollars by allowing private individuals to bring fraud lawsuits on behalf of the federal government.
The justices rejected Lilly's appeal of a lower court's ruling, which upheld a...
Health care entities may be able to pay less than half the steep fines ordinarily associated with False Claims Act (FCA) violations by voluntarily reporting issues under a new pilot program launche...